37 results
8-K
CYCN
Cyclerion Therapeutics Inc
19 Jul 23
Submission of Matters to a Vote of Security Holders
5:27pm
(the “Company”, “we”, or “our”), held a special meeting of shareholders (the “Special Meeting”) in connection with (i) the proposed sale of the assets comprising … ”). Present at the Special Meeting were holders of 1,515,929 shares of Common Stock, in person or by proxy, representing approximately 63
8-K
CYCN
Cyclerion Therapeutics Inc
12 Jul 23
Other Events
12:00am
directors and executive officers is available in Cyclerion’s proxy statement on Schedule 14A for the 2023 special meeting of stockholders, which was filed
DEFM14A
CYCN
Cyclerion Therapeutics Inc
20 Jun 23
Proxy related to merger
4:55pm
, 18th Floor
Cambridge, MA 02142
(857) 327-8778
June 20, 2023
Dear Shareholder:
You are cordially invited to attend a special meeting … webcast. Shareholders will only be able to participate in the special meeting online, vote shares electronically and submit questions during the special
PREM14A
mjv8pik b0ek3
9 Jun 23
Preliminary proxy related to merger
5:23pm
DEFA14A
gm1k39ia1yt
11 May 23
Additional proxy soliciting materials
7:28pm
8-K
EX-2.1
9idjmp v2ebdx6lnj8pb
11 May 23
Cyclerion Announces Definitive Agreement for Zagociguat and CY3018
7:26pm
8-K
ouf0z4gdbi6xxlr
11 May 23
Cyclerion Announces Definitive Agreement for Zagociguat and CY3018
7:26pm
424B4
x8ggbom7fd5ag
24 Jun 21
Prospectus supplement with pricing info
10:33am
424B5
ypimj1dj
3 Sep 20
Prospectus supplement for primary offering
4:54pm
424B4
2cum7
17 Aug 20
Prospectus supplement with pricing info
1:07pm
S-3
o1v9wakj
24 Jul 20
Shelf registration
5:13pm